Objectives: Liver transplantation in hepatocellular cancer (HCC) is curative only for a
selection of patients. Commonly used criteria are mostly based on tumor size and number …

Alpha-fetoprotein (AFP) is the main tumor biomarker available for the management of
hepatocellular carcinoma (HCC). Although it is neither a good screening test nor an …

Background Milan criteria (MC) represent the most commonly adopted criteria for the
selection of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation …

Background Serum α-fetoprotein concentration (AFP) might be a useful addition to
morphologic criteria for selecting patients with hepatocellular carcinoma (HCC) for liver …

Serum alpha‐fetoprotein (AFP) has been increasingly recognized as a marker for a poor
prognosis after liver transplantation (LT) for hepatocellular carcinoma (HCC). Many …

BACKGROUND & AIMS: The aim of this study was to generate an improved prognostic
model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma …

Liver transplantation (LT) is a cornerstone in the management of early-stage hepatocellular
carcinoma (HCC). Despite favorable overall posttransplant survival with the restrictive Milan …

BACKGROUND & AIMS: Liver transplantation is a recognized treatment for selected patients
with hepatocellular carcinoma (HCC), but transplant criteria still need to be refined …

Serum alpha-fetoprotein (AFP) value is still not included in the consensus guidelines to
make decisions referring to liver transplantation (LT) for hepatocellular carcinoma (HCC) …

The role of alpha-fetoprotein (AFP) in the specific setting of the diagnosis and prognosis of
patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT) is still …